Clinical Trial Update: VHAG in Treating R/R T-ALL/LBL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating VHAG for relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• VHAG regimen

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute T Lymphpblastic Leukemia/Lymphoma | Phase 2 | Status: RECRUITING